Delivery Order SPE2DB24D2208-SPE2DB25FHJFL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) with a contract value of $1,713.32. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $2,807.27 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units). The contract utilizes firm fixed pricing with an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,211.16 to AmerisourceBergen Drug Corp for the supply of Primaquine 26.3 mg tablets (100 count) on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Primaquine is an antimalarial medication commonly used by the Department of Defense for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) valued at $1,373.34. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Primaquine 26.3 mg tablets in a quantity of 100 units, with a contract ceiling value of $1,231.50. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract is scheduled for ultimate completion by May 30, 2025, with...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Primaquine 26.3 mg tablets in a quantity of 100 units, valued at $1,816.32 with a firm fixed price structure. This award represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,788.91 to AmerisourceBergen Drug Corp for 100 tablets of Primaquine 26.3 mg. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Primaquine is an antimalarial medication used primarily for the treatment and prevention of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,633.04 firm fixed-price delivery order for Primaquine 26.3 mg tablets (100-count units) with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,669.16 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units). The contract utilizes firm fixed pricing under a non-set-aside competitive procurement and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor and critical federal vendor...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Primaquine 26.3 mg tablets, a pharmaceutical product, with a ceiling value of $1,513.60 and a completion date of June 30, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
- SPE2DB24D2208Indefinite Delivery Contract
- SPE2DB24D2208-SPE2DB25FHJFLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count) with a ceiling value of $1,262.78 under a firm fixed-price contract type. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and was competitively awarded with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Primaquine tablets being procured under this delivery order support military medical requirements, with the company's contract portfolio demonstrating extensive capability in delivering both brand-name and generic medications across multiple therapeutic domains to federal health systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/19/25 |